<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01956825</url>
  </required_header>
  <id_info>
    <org_study_id>MMC13023-13CTIL</org_study_id>
    <nct_id>NCT01956825</nct_id>
  </id_info>
  <brief_title>The Effect Of Dual Treatment With L-Carnitine And Magnesium On Fatty Liver</brief_title>
  <official_title>THE EFFECT OF DUAL TREATMENT WITH L-CARNITINE AND MAGNESIUM ON Patients With Non Alcoholic Fatty Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the dual therapy of the amino acid
      L-CARNITINE and magnesium have an effect on reducing the liver fat content in patients with
      non alcoholic fatty liver disease (NAFLD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine whether the dual therapy of the amino acid
      L-CARNITINE and magnesium have an effect on reducing the liver fat content in patients with
      non alcoholic fatty liver disease.

      the study is an interventional one in which 60 patients who by definition have non alcoholic
      fatty licer disease (NAFLD) are divided randomly (double blind) into 2 groups: group 1:
      &quot;study group&quot;. receive a product (flavoured water) which contains L-CARNITINE an magnesium.
      group 2: control. receive placebo. regular water. Length of trial - 12 weeks. The patients
      will be followed on a weekly base and variuos parameters will be compared (weight, lipid
      profile, insulin resistance etc.).

      &quot;fibrotest&quot; will be used at the beginning of the trial and at the end (week 12) comparing the
      fat content before and after the treatment.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>effect of LCARNITINE and magnesium treatment on the liver fat content</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>effect of L-CARNITINE and magnesium treatment on the metabolic panel</measure>
    <time_frame>12 weeks</time_frame>
    <description>hepatic enzyme profile, lipid profile, weight, inflammatory markers, insulin resistance</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Non Alcoholic Fatty Liver Disease</condition>
  <arm_group>
    <arm_group_label>water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>just water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>L-CARNITINE AND MAGNESIUM (&quot;slim water&quot; product)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental arm will receive a product &quot;slim water&quot;, which contains 150 mg magnesium lactate and 2000 mg L-carnitine. The purpose is to follow the patients and examine several metabolic parameters over time (liver function test, lipid profile, liver fat content, etc.) and by that to show and prove the positive effect of the experimental treatment over placebo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>&quot;slim water&quot;</intervention_name>
    <arm_group_label>L-CARNITINE AND MAGNESIUM (&quot;slim water&quot; product)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        age&gt;18, &lt;80 y evidence to non alcoholic fatty liver disease

        Exclusion Criteria:

        age&lt;18, &gt;80 y pregnancy renal failure congestive heart failure active malignancy liver
        disease - etiology other than non alcoholic fatty liver disease (NAFLD).
        hypothyroidism/cushing total prenteral nutrition (TPN) in the last 6 month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>DAN FELDMAN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Meir Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>DAN FELDMAN, MD</last_name>
    <phone>0522794025</phone>
    <email>danifel100@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>YONA KITAY, MD</last_name>
    <phone>09-7471560</phone>
    <email>yonaki@clalit.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Meir Hospital</name>
      <address>
        <city>Kfar Saba</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DAN FELDMAN, MD</last_name>
      <phone>0522794025</phone>
      <email>danifel100@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>YONA KITAY, MD</last_name>
      <phone>09-7471560</phone>
      <email>yonaki@clalit.org.il</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2013</study_first_submitted>
  <study_first_submitted_qc>October 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2013</study_first_posted>
  <last_update_submitted>October 7, 2013</last_update_submitted>
  <last_update_submitted_qc>October 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>non alcoholic fatty liver disease</keyword>
  <keyword>LCARNITINE amino acid</keyword>
  <keyword>magnesium</keyword>
  <keyword>fat content</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

